Haleon PLC Logo

Haleon PLC

A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+1 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Haleon PLC is a global leader in consumer healthcare, operating as a pure-play business dedicated to improving everyday health. Formerly the consumer healthcare division of GSK, the company's portfolio comprises a wide range of category-leading, over-the-counter (OTC) brands. Its core product areas include oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Key brands under its management include Sensodyne, Panadol, Advil, Voltaren, and Centrum. With a global presence, Haleon focuses on delivering science-backed and trusted health products directly to consumers worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-30 08:10
Earnings Release
Haleon 2025 Q3 Trading Statement
English 410.9 KB
2025-10-30 08:00
Report Publication Announcement
Haleon 2025 Q3 Trading Statement
English 14.7 KB
2025-10-10 13:45
Director's Dealing
Director/PDMR Shareholding
English 39.5 KB
2025-10-02 11:05
Board/Management Information
Director Declaration
English 6.9 KB
2025-10-02 08:00
Transaction in Own Shares
Transaction in Own Shares & Buyback Update
English 19.2 KB
2025-10-01 11:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights and Capital
English 8.1 KB
2025-10-01 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-29 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.9 KB
2025-09-26 14:30
Director's Dealing
Director/PDMR Shareholding
English 115.8 KB
2025-09-24 16:00
Major Shareholding Notification
Holding(s) in Company
English 39.0 KB
2025-09-23 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.1 KB
2025-09-22 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-17 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Haleon PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Icure Pharmaceutical Incorporation Logo
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
South Korea 175250
Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland IDIA
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea 249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea 003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea 007570
ImmuneOncia Therapeutics, Inc. Logo
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea 424870
Immuno-Biological Laboratories Co., Ltd. Logo
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan 4570
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom N/A
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom INDV
Infant Bacterial Therapeutics Logo
Develops live bacterial medicines to prevent rare, severe gut diseases in premature infants.
Sweden IBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.